Blazing Star Merger Sub completes Walgreens debt tender offer
In a recent transaction, West Nadja, a director at Tempus AI , Inc. (NASDAQ:TEM), sold shares of the company amounting to $41,347. The sales took place on March 4, 2025, and involved a total of 809 shares of Class A Common Stock. The shares were sold at prices ranging from $48.40 to $53.24. The transaction comes as InvestingPro data shows TEM trading near $48.86, down about 4% in the past week, with the stock currently appearing overvalued based on Fair Value analysis.
Following these transactions, Nadja retains ownership of 37,705 shares in Tempus AI. These transactions were executed under a Rule 10b5-1 trading plan, which was adopted in December 2024. Despite recent challenges, including negative earnings and operating with moderate debt levels, the company maintains strong liquidity with a current ratio of 2.29. InvestingPro subscribers can access detailed insider trading patterns and 7 additional key insights about TEM’s financial health and market position.
In other recent news, Tempus AI Inc reported strong fourth-quarter earnings for 2024, with a revenue of $700 million, marking a 35.8% increase year-over-year. Despite this growth, the company posted an earnings per share (EPS) of -0.18. The company has also raised its 2025 revenue guidance to approximately $1.24 billion, which includes contributions from Ambry Genetics, surpassing the prior estimate of around $1.23 billion. Stifel analysts maintained their Hold rating for Tempus AI, setting a price target of $65, while JPMorgan downgraded the stock from Overweight to Neutral, despite raising the price target to $55. Tempus AI’s forecast suggests a robust 30% growth in core revenue, consistent with consensus estimates. The company also completed the acquisition of Ambry Genetics and launched the Olivia AI personal health app. Analysts from Stifel and JPMorgan noted that Tempus AI’s stock valuation appears fair compared to peers, with its enterprise value to sales ratio standing at approximately 11 times the 2025 estimate.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.